Literature DB >> 31203400

Pituitary involvement in patients with granulomatosis with polyangiitis: case series and literature review.

Yu Gu1, Xuefeng Sun1, Min Peng1, Ting Zhang1, Juhong Shi1, Jiangfeng Mao2.   

Abstract

GPA with pituitary involvement is a rare condition which is prone to be misdiagnosed. The aim of this study was to summarize clinical features of pituitary involvement in GPA and facilitate early diagnosis. Twelve GPA patients were retrospectively analyzed at a single hospital between 2000 and 2017. A literature review was conducted to compare previous findings with our clinical results. The incidence rate of pituitary involvement in GPA was 3.9% (12/304) without sexual predilection. Other impairments included ear, nose and throat (n = 12), oculi (n = 10), lung (n = 6), meninges (n = 4), kidney (n = 3), and skin (n = 2). Antineutrophil cytoplasmic antibodies (ANCA) were positive in all patients with lung or kidney involvement (n = 6/6), while ANCA were negative in almost all patients without lung or kidney involvement (n = 5/6). Endocrine abnormalities included central diabetes insipidus (CDI, n = 11/12) hypogonadotropic hypogonadism (n = 6/11), adrenocorticotropic hormone deficiency (n = 4/7), thyroid-stimulating hormone deficiency (n = 5/11), and growth hormone deficiency (n = 3/9). Enlarged pituitary gland (n = 6), absence of posterior hyperintense signal on T1-weighed images (n = 11) and hypertrophic cranial pachymeningitis (n = 4) were common radiological manifestations. After treatment, nine patients experienced remission but one died. Pituitary images of 3/4 patients showed size of pituitary lesions decreased. CDI was not alleviated and hypopituitarism remained in two patients. Pituitary involvement in GPA can occur at any time throughout the course of disease, including at the initial presentation. GPA could not be excluded based on negative-ANCA in patients with pituitary abnormality alone. CDI and hypogonadotropic hypogonadism are dominant endocrine abnormalities. Systemic diseases may alleviate and pituitary images may improve after treatment, though the recovery of pituitary function is rare.

Entities:  

Keywords:  Antineutrophil cytoplasmic antibodies; Diagnosis; Granulomatosis with polyangiitis; Hypogonadism; Neurogenic diabetes insipidus

Mesh:

Substances:

Year:  2019        PMID: 31203400     DOI: 10.1007/s00296-019-04338-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

1.  Pituitary involvement by Wegener's granulomatosis: a report of two cases.

Authors:  G L Katzman; C A Langford; M C Sneller; M Koby; N J Patronas
Journal:  AJNR Am J Neuroradiol       Date:  1999-03       Impact factor: 3.825

2.  Diabetes insipidus as the presenting symptom of Wegener's granulomatosis.

Authors:  W M Miesen; E N Janssens; E F van Bommel
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

3.  Sudden death and Wegener's granulomatosis of the pituitary.

Authors:  A Woywodt; H Knoblauch; R Kettritz; W Schneider; U Göbel
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

Review 4.  Pituitary involvement in Wegener's granulomatosis: a case report and review of the literature.

Authors:  Jianling Tao; Yi Dong
Journal:  Chin Med J (Engl)       Date:  2003-11       Impact factor: 2.628

5.  Respirato-renal type of polyarteritis nodosa.

Authors:  C G AHLSTROM; K LIEDHOLM; E TRUEDSSON
Journal:  Acta Med Scand       Date:  1953

6.  Diabetes insipidus presentation before renal and pulmonary features in a patient with Wegener's granulomatosis.

Authors:  Nurşen Düzgün; Yonca Morris; Sevim Güllü; Alptekin Gürsoy; Arzu Ensari; Ozlem Ozdemir Kumbasar; Murat Duman
Journal:  Rheumatol Int       Date:  2005-04-28       Impact factor: 2.631

7.  Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis.

Authors:  Radek Spísek; Elena Kolouchová; Jirí Jensovský; Robert Rusina; Pavel Fendrych; Jaroslav Plas; Jirina Bartůnková
Journal:  Clin Rheumatol       Date:  2005-12-02       Impact factor: 2.980

8.  Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature.

Authors:  E Reinhold-Keller; K de Groot; K Holl-Ulrich; A C Arlt; M Heller; A C Feller; W L Gross
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

9.  Granulomatous hypophysitis due to Wegener's granulomatosis.

Authors:  M Goyal; W Kucharczyk; E Keystone
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

10.  ENT Wegener's granulomatosis can hide severe central nervous system involvement.

Authors:  B Tumiati; G Zuccoli; L Pavone; C Buzio
Journal:  Clin Rheumatol       Date:  2004-11-26       Impact factor: 2.980

View more
  2 in total

1.  Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes.

Authors:  Chunjia Li; Yu Zou; Xin Lu; Guochun Wang; Xiaoming Shu
Journal:  Ther Adv Chronic Dis       Date:  2020-06-09       Impact factor: 5.091

Review 2.  Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease.

Authors:  Fabienne Langlois; Elena V Varlamov; Maria Fleseriu
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.